Cegedim Sa · EURONEXT:ALCGM

Cegedim Sa — Q2 2015 Earnings Presentation

26 slides from Cegedim Sa's earnings presentation, Jul 28, 2015

  1. Slide 1: Q2 2015 Revenue Conference Call

    Q2 2015 REVENUE Conference Call July 28, 2015 at 6:15 CET

  2. Slide 2: Safe Harbor Statement

    SAFE HARBOR STATEMENT This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995). By their nature, forward-looking statements involve risk and uncertainty. Forward-looking statements represent the compa

  3. Slide 3: IFRS 5

    IFRS 5 Cegedim announced on April 1st, 2015, that it had completed the disposal of its CRM and Strategic Data division to IMS Health for an estimated selling price of €396 million. This estimated amount is subject to joint review over a period of 180 business days. Consequently its HY-2015 Financial

  4. Slide 4: HY-2015 Key Takeaways

    HY-2015 Key Takeaways Q2 2015 Revenue – July 2015 4

  5. Slide 5: Agenda

    AGENDA.  Business & Strategy Review  HY 2015 Financial Situation 5

  6. Slide 6: Business & Strategy Review

    Business & Strategy Review

  7. Slide 7: Breakdown of Activities by Division

    Breakdown of Activities by Division Q2 2015 Revenue – July 2015 7

  8. Slide 8: Health Insurance, HR & e-services Division Overview

    Health Insurance, HR & e-services Division Overview Q2 2015 Revenue – July 2015 8

  9. Slide 9: Healthcare Professionals Division Overview

    Healthcare Professionals Division Overview Q2 2015 Revenue – July 2015 9

  10. Slide 10: Cegelease Division Overview

    Cegelease Division Overview Q2 2015 Revenue – July 2015 10

  11. Slide 11: FY 2015 Outlook

    FY 2015 Outlook Q2 2015 Revenue – July 2015 11

  12. Slide 12: HY 2015 Financial Situation

    HY 2015 Financial Situation

  13. Slide 13: HY-2015 Revenue Growth

    HY-2015 Revenue Growth Q2 2015 Revenue – July 2015 13

  14. Slide 14: HY 2015 Performance by Division

    HY 2015 Performance by Division Q2 2015 Revenue – July 2015 14

  15. Slide 15: Use of Proceed from the Health Transaction

    Use of Proceed from the Health Transaction Q2 2015 Revenue – July 2015 15

  16. Slide 16: Upgraded to BB-, Positive Outlook

    Upgraded to BB-, Positive Outlook Q2 2015 Revenue – July 2015 16

  17. Slide 17: Strategic Priorities

    Strategic Priorities Q2 2015 Revenue – July 2015 17

  18. Slide 18: Next Events

    Next Events Q2 2015 Revenue – July 2015 18

  19. Slide 19: Annexes

    Annexes

  20. Slide 20: Cegedim at a Glance

    Cegedim at a Glance Q2 2015 Revenue – July 2015 20

  21. Slide 21: Revenue Breakdown from Continuing Activities

    Revenue Breakdown from Continuing Activities Q2 2015 Revenue – July 2015 21

  22. Slide 22: FY Performance by Division

    FY Performance by Division Q2 2015 Revenue – July 2015 22

  23. Slide 23: Revenue & Organic Q2 Growth Calculation

    Revenue & Organic Q2 Growth Calculation Health Healthcare Activities not Q2‐2015 Insurance, HR & Cegelease Group Professionals allocated e‐services Q2 2014 Revenue a 56,801 37,617 29,971 823 125,211 Impact of disposals 0 0 0 0 0 Q2 2014 Revenue before impact of disposals 56,801 37,617 29,971 823 125

  24. Slide 24: Revenue & Organic HY Growth Calculation

    Revenue & Organic HY Growth Calculation Health Healthcare Activities not HY‐2015 Insurance, HR & Cegelease Group Professionals allocated e‐services HY 2014 Revenue a 106,602 74,523 55,838 1,619 238,581 Impact of disposals 0 0 0 0 0 HY 2014 Revenue before impact of disposals 106,602 74,523 55,838 1,6

  25. Slide 25: 2015 Financial Agenda

    2015 Financial Agenda Q2 2015 Revenue – July 2015 25

  26. Slide 26: We welcome your questions and comments

    We welcome your questions and comments Jan Eryk UMIASTOWSKI Chief Investment Officer - Head of Investor Relations janeryk.umiastowski@cegedim.com

Cegedim — Q2 2015 Earnings Presentation on 6ix